InMed Pharmaceuticals Inc. (INM)
Market Closed
15 Oct, 08:00 PM
$
1. 33
+0.02
+1.5267%
Pre Market
$
+0.13 +9.7744% 1. 46
7.47M Market Cap
- P/E Ratio
- Div Yield
17,600 Volume
0 Eps
$ 1.31
Previous Close Investors:
Want to track INM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
Seekingalpha | 4 months ago
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
InMed Pharmaceuticals Inc. (INM) Shareholder/Analyst Call Prepared Remarks Transcript
Seekingalpha | 10 months ago
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday
On Tuesday, InMed Pharmaceuticals Inc. INM confirmed INM-901 as an oral formulation that will be utilized in its development programs for Alzheimer's disease.
Benzinga | 2 years ago
2026 © Marketlog. All Rights Reserved.
